KPRX Kiora Pharmaceuticals: Net earnings per share growth forecast for next year

Corporate company logo of Kiora Pharmaceuticals Inc. (KPRX)

Kiora Pharmaceuticals (KPRX) is scaling its ophthalmology programs for the therapy of retinal pathologies, targeting B2B partnerships. This earnings per share forecast chart visualizes this trajectory, where the 31.00 mark characterizes this parameter. A diversified drug pipeline mitigates regulatory risks, while unique light-activated molecules create potential for pricing power in the treatment of genetic vision defects.

KPRX: Kiora Pharma Consensus forecast of earnings per share growth for next year 07/04/2022 - 11/15/2026

Kiora Pharmaceuticals Inc. - analytical breakdowns and key metrics (KPRX)

Basic company analysis:Kiora Pharmaceuticals Inc.
Core merchandise of Kiora Pharmaceuticals, Inc.

This indicator reflects the consensus earnings per share (EPS) growth forecast, measuring market expectations for future business returns rather than analyzing historical periods. The current valuation of next year's EPS growth is critical for Kiora Pharmaceuticals (KPRX), as it allows for an assessment of the monetization potential of unique light-sensitive molecules and commercial success within the rare retinal disease therapy segment.

Competitor analysis for Kiora Pharmaceuticals

ALC (Alcon Corp) - Earnings growth forecast for next year|Bausch + Lomb Corporation (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GKOS|Earnings growth forecast for next year Apellis Pharmaceuticals, Inc. (APLS)|Earnings growth forecast for next year BLTE (Belite Bio)|OCUL - Expected earnings per share growth for next year|HROW - Net earnings per share growth forecast for next year|Expected earnings per share trend next year VRDN (Viridian Therapeutics)|LENZ (LENZ Therapeutics, Inc.) - Expected earnings per share growth for next year|Oculis Holding AG - Expected earnings per share trend next year|Net earnings per share growth forecast for next year eyepointpharma.com|Earnings growth forecast for next year Kodiak Sciences Inc.|Net earnings per share growth forecast for next year Aldeyra Therapeutics Inc. (ALDX)|Net earnings per share growth forecast for next year KALA (KALA BIO)|Net earnings per share growth forecast for next year opusgtx.com IRD|Expected earnings per share trend next year OKYO|ADVM: Expected earnings per share growth for next year|Expected earnings per share trend next year OTLK (Outlook Therapeutics)|CLSD: Earnings growth forecast for next year|NovaBay Pharmaceuticals Inc. - Expected earnings per share trend next year|ALIM (alimerasciences.com) - Earnings growth forecast for next year|eyenovia.com (EYEN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GHSI|OCUP (Ocuphire) - Expected earnings per share trend next year|Earnings growth forecast for next year OPT (Opthea Ltd)